CAS RN: 1363382-82-4
Methyl 2-broMoiMidazo[1,2-a]pyridine-8-carboxylate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250702
100mg / 500mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1363382-82-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
1363382-82-4 / methyl 2-bromoimidazo[1,2-a]pyridine-8-carboxylate
Standard CAS: 1363382-82-4
Multi CAS: No
Basic Information
copy
CAS
1363382-82-4 copy
Multi CAS
No copy
Molecular Formula
C9H7BrN2O2 copy
Molecular Weight
255.070000 copy
Exact Mass
253.969090 copy
SMILES
COC(=O)C1=CC=CN2C1=NC(=C2)Br copy
InChI
InChI=1S/C9H7BrN2O2/c1-14-9(13)6-3-2-4-12-5-7(10)11-8(6)12/h2-5H,1H3 copy
InChIKey
AHRNKKKJBWWDTO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.11 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
54.23 copy
TPSA
43.6 copy
LogP / Solubility
WLOGP
1.88 copy
MLOGP
1.66 copy
XLogP3
2.6 copy
Consensus LogP
2.05 copy
Log S (ESOL)
-3.02 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.01 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.94 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy